Today's pre-market stock movers: NVAX, MRNA, NCLH, MU and more

• $GoodRx (GDRX.US)$ +38.5%, $EDGIO (EGIO.US)$ +13.5%, $Lemonade (LMND.US)$ +10.7%, $Desktop Metal (DM.US)$ +8.5%, $ShockWave Medical (SWAV.US)$ +8.2%, $Pubmatic (PUBM.US)$ +8.1%, $Olaplex (OLPX.US)$ +7%, $Vivid Seats (SEAT.US)$ +6.4%, $Noble (NE.US)$ +6.3%, $Aspen Technology (AZPN.US)$ +5.4%, $AAON Inc (AAON.US)$ +5%, $Hudbay Minerals (HBM.US)$ +5%, $Vivint Smart Home (VVNT.US)$ +4.9%, $Vivint Smart Home (VVNT.US)$ +4.7%, $Hims & Hers Health (HIMS.US)$ +4.6%, $RadNet (RDNT.US)$ +4%, $GlobalFoundries (GFS.US)$ +3.9%, $Vertex (VERX.US)$ +3.1%, $Ebix Inc (EBIX.US)$ +2.4%, $Helios Technologies (HLIO.US)$ +2.1%, H +2.1%, $EVgo Inc (EVGO.US)$ +1.9%

• $Verona Pharma (VRNA.US)$ +59.3% (Ensifentrine Meets Primary Endpoint in Phase 3 ENHANCE-2 Trial for COPD; also reported earnings)

• $Mersana Therapeutics (MRSN.US)$ +19.4% (MRSN announces collaboration with GSK granting option to co-develop and commercialize XMT-2056)

• $Startek (SRT.US)$ +15.9% (received non-binding proposal from CSP Management Limited to acquire SRT for $4.65/share in cash)

• $The Beauty Health (SKIN.US)$ +8.4% (Luxor Capital Group discloses 5% passive stake)

• $RxSight (RXST.US)$ +7.9% (files for $200 mln mixed securities shelf offering)

• $MDU Resources (MDU.US)$ +4.7% (Corvex discloses 4.99% active stake; intends to enter into discussions)

• $Valneva (VALN.US)$ +3.8% (PFE and VALN announce initiation of a Phase 3 clinical study)

• $Inspirato (ISPO.US)$ +5.1% (upgraded to Overweight from Neutral at Cantor Fitzgerald)

• $Tellurian (TELL.US)$ +4.4% (upgraded to Buy from Neutral at BofA Securities)

• $Novavax (NVAX.US)$ -32.6%, $Cerence (CRNC.US)$ -21%, $CarGurus (CARG.US)$ -15%, $23andMe (ME.US)$ -14.3%, $3D Systems (DDD.US)$ -13.8%, $Upstart (UPST.US)$ -13.4%, $Allbirds (BIRD.US)$ -12.5%, $Cronos Group (CRON.US)$ -12%, $Freshpet (FRPT.US)$ -11.9%, $Vroom (VRM.US)$ -11.8%, $Bausch Health (BHC.US)$ -11.5%, $Clover Health (CLOV.US)$ -11.2% (also to transition role of CEO toco-founder Andrew Toy), $Avaya Holdings (AVYA.US)$ -10.8%, $TaskUs (TASK.US)$ -10.6%,

• $Trex Co. (TREX.US)$ -9.9% (expects a significant reduction in revs in 2H22), $LivePerson (LPSN.US)$ -9.8%, $AdaptHealth (AHCO.US)$ -9.8%, $eHealth (EHTH.US)$ -9.4%, $SmileDirectClub (SDC.US)$ -8.5%, $Blink Charging (BLNK.US)$ -8.4%, $Oportun Financial (OPRT.US)$ -7.1%, $ACCO Brands (ACCO.US)$ -6.7%, $Clarivate (CLVT.US)$ -6.7%, $Westport Fuel (WPRT.US)$ -5.8%, $ICU Medical (ICUI.US)$ -5.8%, $Reynolds Consumer Products (REYN.US)$ -5.5%, $Norwegian Cruise (NCLH.US)$ -4.8%, $Vaxart (VXRT.US)$ -4.7%, $Hain Celestial (HAIN.US)$ -4.6%, $National CineMedia (NCMI.US)$ -4.5%, $Kymera Therapeutics (KYMR.US)$ -4.5%, $Micron Technology (MU.US)$ -4.2% (lowers guidance), $FibroGen (FGEN.US)$ -4.1%(also files mixed securities shelf offering), $Take-Two Interactive Software (TTWO.US)$ -3.4%, $Signet Jewelers (SIG.US)$ -3.2% (lowersguidance;also acquires Blue Nile for $360mln incash), $Groupon (GRPN.US)$ -1.2%

• $CorMedix (CRMD.US)$ -57.3% (receives a second CRL regarding DefenCath NDA)

• $Turtle Beach (HEAR.US)$ -31.3% (provides update on strategic review; will remain a standalone business; also reports earnings)

• $Quanterix (QTRX.US)$ -27.5% (exec chairman stepping down)

• $BellRing Brands (BRBR.US)$ -7.7% (prices offering of 14.8 mln shares of common stock at $23.50 per share)

• $Rallybio (RLYB.US)$ -6.6% (files for $300 mln mixed securities shelf offering)

• $Sovos Brands (SOVO.US)$ -6.5% (stock offering)

• $PennantPark (PFLT.US)$ -6.4% (prices offering of 4.0 mln shares of commonstock at $12.40 per share)

• $Canoo (GOEV.US)$ -5.8% (files mixed securities shelf offering)

• $SIGA Technologies (SIGA.US)$ -3.5%(announces exercise of procurement options with Dept, of HHS for TPOXX treatment courses valued at approx. $26mln)

• $Arcus Biosciences (RCUS.US)$ -3.4%(names new CMO)

• $Portillo’s Inc. (PTLO.US)$ -3.3%(stock offering)

• $Broadmark Realty Capital (BRMK.US)$ -6.3% (downgraded to Underweight from Neutral at Piper Sandler)

• $Aemetis (AMTX.US)$ -3.8% (downgraded to Hold from Buy at Truist)

• $Tandem Diabetes Care (TNDM.US)$ -3.1% (downgraded to Underweight from Overweight at Wells Fargo)